StonvexLoading…
StonvexStonvexStonvexCore line items from UCTT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-27 | Annual 2023 2023-12-29 | Q3 2023 2023-09-29 | Q2 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $2.10B | $1.73B | $1.29B | $854.80M |
Operating Income | $91.20M | $35.20M | $30.70M | $25.00M |
Net Income | $23.70M | $-31.10M | $-27.30M | $-12.80M |
EPS (Diluted) | $0.52 | $-0.70 | $-0.61 | $-0.29 |
Total Assets | $1.92B | $1.87B | $1.85B | $1.84B |
Total Liabilities | $984.10M | $970.50M | $950.40M | $937.50M |
Cash & Equivalents | $313.90M | $307.00M | $342.00M | $320.80M |
Free Cash Flow OCF − CapEx | $1.50M | $60.10M | $41.40M | $17.40M |
Shares Outstanding | 45.10M | 44.60M | 44.80M | 44.80M |